EE9700065A - Uus keemiline ühend, selle valmistamine ja kasutamine ravimina - Google Patents

Uus keemiline ühend, selle valmistamine ja kasutamine ravimina

Info

Publication number
EE9700065A
EE9700065A EE9700065A EE9700065A EE9700065A EE 9700065 A EE9700065 A EE 9700065A EE 9700065 A EE9700065 A EE 9700065A EE 9700065 A EE9700065 A EE 9700065A EE 9700065 A EE9700065 A EE 9700065A
Authority
EE
Estonia
Prior art keywords
medicine
preparation
chemical compound
new chemical
new
Prior art date
Application number
EE9700065A
Other languages
English (en)
Estonian (et)
Inventor
John Montague Meade Christopher
Anderskewitz Ralf
Schromm Kurt
Renth Ernst-Otto
Birke Franz
F�gner Armin
Heuer Hubert
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of EE9700065A publication Critical patent/EE9700065A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9700065A 1994-07-13 1995-06-03 Uus keemiline ühend, selle valmistamine ja kasutamine ravimina EE9700065A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4424714A DE4424714A1 (de) 1994-07-13 1994-07-13 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
PCT/EP1995/002113 WO1996002496A1 (de) 1994-07-13 1995-06-03 Neue chemische verbindung, ihre herstellung und ihre verwendung als arzneistoff

Publications (1)

Publication Number Publication Date
EE9700065A true EE9700065A (et) 1997-08-15

Family

ID=6523048

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700065A EE9700065A (et) 1994-07-13 1995-06-03 Uus keemiline ühend, selle valmistamine ja kasutamine ravimina

Country Status (25)

Country Link
US (1) US5686496A (ko)
EP (1) EP0770058A1 (ko)
JP (1) JPH10502646A (ko)
KR (1) KR970704674A (ko)
CN (1) CN1152303A (ko)
AU (1) AU2736895A (ko)
BG (1) BG101104A (ko)
BR (1) BR9508395A (ko)
CA (1) CA2194886A1 (ko)
CO (1) CO4410185A1 (ko)
CZ (1) CZ8297A3 (ko)
DE (1) DE4424714A1 (ko)
EE (1) EE9700065A (ko)
FI (1) FI970095A0 (ko)
HR (1) HRP950363A2 (ko)
HU (1) HUT76827A (ko)
IL (1) IL114572A0 (ko)
MX (1) MX9700245A (ko)
NO (1) NO970123D0 (ko)
PE (1) PE35196A1 (ko)
PL (1) PL318114A1 (ko)
SK (1) SK1897A3 (ko)
WO (1) WO1996002496A1 (ko)
YU (1) YU45395A (ko)
ZA (1) ZA955781B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
AU5857296A (en) * 1995-05-17 1996-11-29 Eli Lilly And Company Use of leukotriene antagonists for alzheimer's disease
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
EP1353661A2 (en) * 2001-01-16 2003-10-22 Boehringer Ingelheim Pharma GmbH & Co.KG Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
KR20040036908A (ko) * 2001-08-31 2004-05-03 뉴로겜 인터내셔널 리미티드 아밀로이드증 치료용 아미딘 유도체
WO2004099783A2 (en) * 2003-05-06 2004-11-18 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor ltb4 (ltb4)
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
KR100682199B1 (ko) * 2004-07-05 2007-02-12 동화약품공업주식회사 알러지성 염증 질환의 예방 및 치료용 조성물
JP3983272B2 (ja) * 2004-07-14 2007-09-26 有限会社 炎症研究所 腫瘍転移の抑制方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
AU673343B2 (en) * 1992-02-05 1996-11-07 Boehringer Ingelheim International Gmbh Novel amidine derivatives, their preparation and their use as mediaments with LTB4 antagonistic effect

Also Published As

Publication number Publication date
SK1897A3 (en) 1997-08-06
MX9700245A (es) 1997-05-31
ZA955781B (en) 1996-02-22
CZ8297A3 (en) 1997-09-17
PE35196A1 (es) 1996-09-05
FI970095A (fi) 1997-01-10
HUT76827A (en) 1997-11-28
BR9508395A (pt) 1997-12-23
EP0770058A1 (de) 1997-05-02
WO1996002496A1 (de) 1996-02-01
NO970123L (no) 1997-01-10
AU2736895A (en) 1996-02-16
HRP950363A2 (en) 1997-08-31
DE4424714A1 (de) 1996-01-18
CN1152303A (zh) 1997-06-18
HU9700060D0 (en) 1997-02-28
KR970704674A (ko) 1997-09-06
YU45395A (sh) 1997-12-05
JPH10502646A (ja) 1998-03-10
IL114572A0 (en) 1995-11-27
FI970095A0 (fi) 1997-01-10
CO4410185A1 (es) 1997-01-09
BG101104A (en) 1998-04-30
US5686496A (en) 1997-11-11
NO970123D0 (no) 1997-01-10
PL318114A1 (en) 1997-05-12
CA2194886A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
FI961219A (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
FI950709A0 (fi) Organometalliset fluorenyyliyhdisteet, valmistus ja käyttö
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
FI955235A0 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE200300236A (et) 1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
FI955913A (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE9700065A (et) Uus keemiline ühend, selle valmistamine ja kasutamine ravimina
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
DK1033990T3 (da) 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
EE05187B1 (et) Hirudiini prekursor, selle kasutamine ja meetod Leu-hirudiini valmistamiseks
FI964031A (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
EE03690B1 (et) Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine
FI953956A0 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
TR199501553A2 (tr) Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.
EE9600180A (et) Anti-HIV kompositsioon, meetod selle valmistamiseks ja selle kasutamine
TR26907A (tr) Yeni poliiodine bilesikleri, hazirlik prosesi ve bunlari iceren kontrast maddesi.
FI956120A0 (fi) Propeenipolymeeri, menetelmä sen valmistamiseksi ja sen käyttö
IT1277138B1 (it) Composti tetrakisazoici, loro preparazione e loro impiego come coloranti.
IT8919089A0 (it) Nuove polioxazolidine, procedimento per la loro preparazione e loro impiego.
ID26780A (id) Senyawa-senyawa tienopiridina, hasil dan kegunaannya